Gallagher's Flawless Adjusted Quarter Comes With an M&A Confession

26 straight quarters of double-digit EBITDA growth and a 21% rally into the print — then the CEO admits his own deal pipeline is smaller than the numbers he used to give you.

AJG · Earnings Call · 2026-10-29

A quarter that beat the story it was supposed to tell

Arthur J. Gallagher delivered on nearly everything it controls. Total revenue rose 18%, brokerage organic growth came in at 5%, Gallagher Bassett posted 10% organic, and adjusted EBITDA grew 25% — the 26th consecutive quarter of double-digit EBITDA growth. Brokerage adjusted EBITDA margin landed at 35.3%, with “Underlying brokerage margins expanded 60 basis points in the quarter” — Douglas K. Howell, Chief Financial Officer · 2026-10-29 on top of 310 basis points of lift from Assured Partners. The stock had already figured this out. AJG rallied 21.5% in the last 90 trading days, one clean up-leg, even though it still sits 23% below its June 2025 peak of $348.77. So the interesting part of this call is not the print — it's the two places where the narrative stops matching the historical script. Start with the gap between the adjusted story and the accounting reality. The last filed 10-Q (Q2 2026) shows operating income down 12% year over year with an operating margin of 10.3% against a 16.2% peak. Interest coverage has slid to 2.5x from a peak of 8.9x in 2023Q1, and effective net cash swung to −$12.2 billion from +$3.6 billion in early 2025. None of that is alarming for a broker generating this much free cash and holding $3.4 billion of future tax savings — Doug Howell is explicit that cash taxes run around 10% of EBITDA — but it does mean the adjusted number is now doing more work than it used to.

Then it gets even better when you levelize to remove the $76 million of interest income we earned in the 3rd quarter ’25 on the funds we are holding to buy Assured Partners. On that basis, adjusted revenues were up 20%, adjusted EBITDA grew 34%, Adjusted EPS grew 37%.
Douglas K. Howell, Chief Financial Officer · 2026-10-29

That is an honest and unusually technical adjustment, and it cuts both ways: the headline 26% EPS growth is genuinely 37% once you strip out the prior-year float income, but it also shows how much of last year's comp was financial rather than operational.

Rates are now worth one point, and everyone knows it

The pricing environment has stopped being a growth engine and become a modest tailwind. Property renewal premiums fell 6% — better than the 10% decline in Q2, though Pat Gallagher is careful to attribute that to renewal mix and seasonality rather than a market turn. Ex-property, renewal premium changes ran +3%, with casualty +4%, professional lines +2%, workers' comp +1%. The CEO's summary is the cleanest sentence in the transcript: “Call it about a point of organic growth today is tied to rates.” — J. Patrick Gallagher, Jr., Chairman of the Board and Chief Executive Officer · 2026-10-29 He expects that point to persist into 2027. The opt-in thesis — clients using property savings to buy back coverage, raise limits, lower deductibles — remains the load-bearing wall of the organic story. It was the argument a year ago too, when Howell described “this opt-in era when it comes to coverages” — Douglas Howell, Chief Financial Officer · 2025-10-30. What's new is that the argument is now carrying more weight with less rate underneath it: legacy brokerage organic in 2027 is guided to look "a lot like '26," minus 40–50 basis points for the AP roll-in, with margin expansion of 50–75 points at 5% organic. Notice what has quietly stopped being a headline. A quarter ago the AI margin math was a set-piece — 600 basis points of potential expansion, two-thirds harvestable. Today AI appears once, in passing, as something that "helps to accelerate that journey." The productivity narrative has been reassigned to centers of excellence, now 20,000 colleagues strong, with the CFO arguing that headcount per dollar of revenue is "an antiquated measure" and the comp ratio is the real tell. When a company stops selling its AI story as a story, that is worth flagging.

The confession on M&A

The second strategic pillar took a visible dent. Gallagher closed 21 acquisitions year-to-date for roughly $225 million of annualized revenue, with 30-plus term sheets representing about $300 million still pending — and then the CEO voluntarily undercut his own pipeline:

I think it is starting to slow down. And frankly, that $300 million is probably off with the numbers that we’ve told you in past years.
J. Patrick Gallagher, Jr., Chairman of the Board and Chief Executive Officer · 2026-10-29

That is a different Gallagher than the one from January, when Howell said “I believe that we have substantial opportunity to continue to clip off 50 to 75 deals a year and not even blink” — Douglas K. Howell, Chief Financial Officer · 2026-01-29. Gallagher's explanation is credible — owner-operators don't have to sell, multiples have reset from the high teens to 9–11x, and there is a "typical lull" while sellers absorb that. But it is a contrast with the reported cohort: Aon is carrying a pending USI acquisition, WTW a pending BMS Re deal, both announced this week. Gallagher, the most acquisitive broker of the last two decades, is the one describing the market as stalled. That leaves $580 million of buybacks through September as the visible use of capital, with roughly $100 million in Q3 alone, against a stated $12 billion of acquisition capacity over two years. The capacity is real; the deployment cadence is the question. Watch the December investor day for term-sheet growth.

The quiet drift inside Assured Partners and benefits

Two soft spots deserve more attention than they got. First, AP organic growth has drifted to about 3.5% from the "around 4%" cited in July (“We’re running around 4% right now with AssuredPartners” — Doug Howell, Chief Financial Officer · 2026-07-30), and management now frames closing that gap as a cultural victory rather than a P&L event. Howell is refreshingly blunt that a point and a half on $3.5 billion is roughly $15 million of EBITDA — noise against $5.5–6 billion. Fine. But he also concedes AP base organic growth is not in the AP synergies assumptions, which makes it free optionality rather than guidance. Second, employee benefits slipped again. Roughly “$4 million of consulting projects that got, got, got deferred” — Douglas K. Howell, Chief Financial Officer · 2026-10-29 plus a few million of large projects and a contingent commission true-up, all attributed to HR leaders consumed by medical and prescription cost inflation. Small dollars; second consecutive quarter of the same explanation; and it undercuts the idea that benefit-cost pain automatically converts into Gallagher advisory revenue. What has genuinely gone quiet is large life sales, which dominated the Q4 2025 and Q1 2026 calls as a swing factor in organic growth. Asked directly, Howell says it shouldn't affect the reported organic numbers "at all." That is a keyword losing its place in the narrative — usually a good sign, occasionally a sign it has been reclassified out of sight. And the E&S market question arrived for the fifth consecutive quarter: is business migrating back to admitted carriers? The answer remains no, and Gallagher's actual differentiation argument is worth more attention than the rate debate — white space inside existing accounts, where the CEO notes that less than 15% of the time is he bidding against a similarly sized peer. That, plus a hit ratio moving from the low 30s toward 45–50% on tooled opportunities, is a better explanation for why Gallagher isn't stumbling alongside competitors than any commentary about middle market conditions. The quarter was excellent. The stock has already paid for excellent. What remains unresolved is whether the second growth cylinder can restart while the first is down to a single point of rate — and whether a $12.2 billion net debt position leaves enough room to buy the answer.